The Use of Immunoblotting to Detect Antibodies to Nuclear and Cytoplasmic Antigens

References

• Tan E M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982; 33: 167–240
   PubMed Web of Science ®Google Scholar
• Lerner M R, Steitz J. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76: 5495–99
   PubMed Web of Science ®Google Scholar
• Van Venrooij W J, Habets W J, de Rooij D J, Van de Putte L B. The molecular composition of nuclear and cytoplasmic antigens: a review. Rheumatology - 85, P M Brooks, J R York. Excerpta Medica, Amsterdam 1985; 175–80
   Google Scholar
• Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Sharp G C, Irvin W S, Tan E M, Gould R G, Holman H R. Mixed connective tissue diease–An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extract-able nuclear antigen (ENA). Am J Med 1972; 52: 148–59
   PubMed Web of Science ®Google Scholar
• Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
   PubMed Web of Science ®Google Scholar
• Alexander E L, Hirsch T J, Arnett F C, Provost T T, Stevens M B. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol 1982; 9: 239–46
   PubMed Web of Science ®Google Scholar
• Bohan A, James J B, Bowman R L, Pearson C M. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255–86
   PubMed Web of Science ®Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R A. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Kurata N, Tan E M. Identification of antibodies to nuclear acidic antigens by counterimmunoelec-trophoresis. Arthritis Rheum 1976; 19: 574–82
   PubMed Web of Science ®Google Scholar
• Habets W J, de Rooij D J, Salden M H, et al. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 1983; 54: 265–76
   PubMed Web of Science ®Google Scholar
• Habets W T, de Rooij D J, Hoet M H, Van de Putte L B, Van Venrooij W J. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol 1985; 59: 457–66
   PubMed Web of Science ®Google Scholar
• Habets W J, Berden J H, Hoch S, Van Venrooij W T. Further characterization and subcellular localization of Sm and Ul ribonucleoprotein antigens. Eur J Immunol 1985; 15: 992–7
   PubMedGoogle Scholar
• Pettersson J, Hinterberger M, Mimori T, Gottlieb E, Steitz J A. The structure of mammalian small nuclear ribonucleoproteins. J Biol Chem 1984; 259: 5907–14
   PubMedGoogle Scholar
• Rinke J, Steitz J A. Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies. Cell 1982; 29: 149–59
   PubMed Web of Science ®Google Scholar
• Habets W J, den Brok J H, Boerbooms A M, Van de Putte L B, Van Venrooij W J. Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells. EMBO J 1983; 2: 1625–31
   PubMedGoogle Scholar
• Wolin S L, Steitz J A. The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci USA 1984; 81: 1996–9
   PubMed Web of Science ®Google Scholar
• Guldner H H, Lakomek H J, Bautz F A. Human anti-centromere sera recognise a 19.5 kD nonhistone chromosomal protein from HeLa cells. Clin Exp Immunol 1984; 58: 13–20
   PubMedGoogle Scholar
• Earnshaw W, Bordwell B, Marino C, Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 1986; 77: 426–30
   PubMed Web of Science ®Google Scholar
• Douvas A S, Achten M, Tan E M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem 1979; 254: 10514–22
   PubMed Web of Science ®Google Scholar
• Shero J H, Bordwell B, Rothfield N F, Earnshaw W C. High titers of autoantibodies to topoisomer-ase I (Scl-70) in sera from scleroderma patients. Science 1986; 231: 737–40
   PubMed Web of Science ®Google Scholar
• Van Venrooij W J, Stapel S O, Houben H, et al. Scl-86, a marker antigen for diffuse scleroderma. J Clin Invest 1985; 75: 1053–60
   PubMedGoogle Scholar
• Maul G G, French B T, Van Venrooij W J, Jimenez S A. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc Natl Acad USA 1986; 83: 5145–9
   PubMed Web of Science ®Google Scholar
• Mathews M B, Bernstein R M. Myositis autoantibody inhibits histidyl-t RNA synthetase: a model for autoimmunity. Nature 1983; 304: 177–83
   PubMed Web of Science ®Google Scholar
• Bernstein R M, Bunn C C, Hughes G R, Francoeur A M, Mathews M B. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984; 2: 105–20
   PubMedGoogle Scholar
• McHugh W J, Maddisson P J. Immunoblotting profiles in systemic lupus erythematosus (abstract). Arthritis Rheum 1987; 30: S54
   Google Scholar
• Sillekens P T, Habets W J, Beijer R P, Van Venrooij W J. cDNA cloning of the human Ul snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific protein. EMBO J 1987; 6: 3841–8
   PubMed Web of Science ®Google Scholar
• Kallenberg C G, Wouda A A, Hoet M H., van Venrooij W J. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six-year follow-up with emphasis on the predictive value of anti-nuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47: 634–41
   PubMed Web of Science ®Google Scholar
• Williams D G, Stocks M R, Charles P J, Maini R N. Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterim-munoelectrophoresis and immunodiffusion using sera from patients with systematic lupus erythematosus and Sjögren's syndrome. J Immunol Meth 1986; 91: 65–73
   PubMedGoogle Scholar
• Harley J B, Alexander E L, Bias W B, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986; 29: 196–206
   PubMed Web of Science ®Google Scholar